ASX-listed shares of Hera Med rise on MoU with US-based FemBridge
18/12/2023 03:31
** ASX-listed shares of Israel-based Hera Med HMD.AX rise
as much as 30% to A$0.026
** Stock set for best day since Nov. 8, if gains hold
** Pregnancy monitoring product maker enters into memorandum
of understanding (MoU) with U.S.-based FemBridge to develop
maternity care solution
** Parties will collaborate to integrate HMD's proprietary
offering HeraCARE into a comprehensive service offering and
source grants and payment options best suited to the offer
** About 994,047 shares change hands, 4.8 times the 30-day
average volume of 206,953 shares
** Stock has fallen 84% this year, as of last close
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.Kumar@thomsonreuters.com;))